Parabilis Medicines, Inc. Common Stock (PBLS : NASDAQ)
Common Stock
$28.53
USD
+0.65 (2.33%)
Last updated: 2026-11-06
Follow PBLS
PBLS
Parabilis Medicines, Inc. Common Stock
WealthAwesomePerformance
1 Day
+2.33%
1 Week
+0.74%
1 Month
-1.01%
YTD
+9.60%
Key Statistics
Market Cap
$3.52B
52W High
$42.49
52W Low
$22.66
P/E Ratio
-
50 Day MA
$31.91
200 Day MA
$32.05
Beta
-
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 11/6/2026 | $27.88 | $28.87 | $27.11 | $28.53 | $28.53 | 629,300 |
| 11/5/2026 | $30.13 | $30.13 | $27.55 | $27.88 | $27.88 | 920,736 |
| 11/4/2026 | $30.00 | $30.83 | $28.70 | $30.36 | $30.36 | 842,946 |
| 11/3/2026 | $28.25 | $29.73 | $27.90 | $29.25 | $29.25 | 518,801 |
| 11/2/2026 | $28.13 | $28.55 | $26.87 | $27.25 | $27.25 | 702,232 |
| 10/30/2026 | $28.59 | $28.74 | $27.48 | $28.32 | $28.32 | 814,000 |
| 10/29/2026 | $28.32 | $30.08 | $27.19 | $28.70 | $28.70 | 844,732 |
| 10/28/2026 | $26.24 | $28.29 | $26.14 | $28.17 | $28.17 | 1,397,331 |
| 10/27/2026 | $25.00 | $27.36 | $24.75 | $26.51 | $26.51 | 1,572,596 |
| 10/26/2026 | $25.01 | $25.59 | $23.06 | $25.03 | $25.03 | 1,427,693 |
Analyst Price Targets
Based on 6 analysts covering PBLS · as of Oct 26, 2026
Wall Street analysts forecast PBLS stock price to rise 45.1% over the next 12 months.
Consensus
Strong Buy5.00 / 5.00
Avg. Target
US$41.40
+45.1% Upside
Previously US$41.75 on Oct 5, 2026
Current Price
US$28.53
Last close
Analyst Breakdown (6 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on PBLS's historical volatility
30-Day Vol
83.3%
Annualized
90-Day Vol
73.3%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
US$23.86
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$26.88 | US$20.17 – US$35.83 |
| 60 trading days | US$25.33 | US$16.87 – US$38.03 |
| 90 trading days | US$23.86 | US$14.51 – US$39.26 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Parabilis Medicines, Inc. Common Stock
Parabilis Medicines, Inc. operates as a clinical-stage biopharmaceutical company focused on developing helical peptide therapeutics for disease treatment. The company develops stabilized helical peptide therapeutics through its Helicon discovery platform, targeting proteins that are traditionally considered undruggable. Its pipeline includes functional inhibitors of intracellular protein-protein interactions, targeted protein degraders, and targeted radiopharmaceuticals, with a lead clinical program, FOG-001, that acts as a TCF-blocking beta-catenin inhibitor for cancer treatment. The company integrates artificial intelligence and data science into drug discovery, trial design, and clinical strategy optimization. Parabilis Medicines serves clients in the healthcare and life sciences industries, including clinical research organizations and medical professionals involved in oncology and cancer treatment. The company was founded in 2015 and is based in Cambridge, Massachusetts.
Financials
- Revenue (TTM)
- $148,000
- EBITDA
- $-169.11M
- Profit Margin
- 0.00%
- ROE (TTM)
- 0.00%
- EPS (Diluted)
- -9.51
- Book Value
- 8.48
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About PBLS.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| ALPS | Alps Group Inc | $1.65 | +424.50% |
| SDA | SunCar Technology Group Inc. | $0.38 | +145.12% |
| STAK | STAK Inc. Ordinary Shares | $3.26 | +82.12% |
| NEXR | Nexera Technologies Ltd. | $2.10 | +75.73% |
| GOGO | Gogo Inc | $3.88 | +71.52% |
| CDT | CDT Equity Inc. | $1.31 | +55.95% |
| CIIT | Tianci International, Inc. Common Stock | $2.40 | +54.84% |
| VSA | VisionSys AI Inc. | $2.35 | +52.60% |
PBLS.US news timeline
1 article covering PBLS.US, most recent first
Latest